Member Info for MrHumbles

'But the promise, not the delivery'

Where have we seen that before?

A case of, forget what you read. Trust management for a few years. LOOOL

Not great. bad few months ahead once the gerbils buy the headline marketing

Overall: Croda delivered 6.6% constant currency sales growth in 2025 and a 7.9% increase in adjusted operating profit, both in line with guidance. However, IFRS operating profit fell from £227.5m to £110.1m, reflecting £107.3m of impairment charges including the decision to place the Lamar lipids facility on standby, a facility built largely on US Government pandemic preparedness funding that is now generating no revenue and carrying an onerous contract obligation for ten years. ROIC is 8.2%, below cost of capital. Adjusted operating margin improved 20 basis points to 17.4%, against a 2028 target of 20%+, with the gap to target heavily dependent on a transformation programme that has delivered £28m of £100m targeted benefits. Free cash flow fell to £161.6m from £169.6m. The dividend was increased 1p to 111p at a pay-out ratio of 76%, materially above the stated 40-50% policy. The balance sheet is stable with leverage at 1.3x but USPP debt of £131m matures in June 2026. In short, the business is stabilising after a difficult few years but the investment case rests almost entirely on transformation delivery and margin recovery that remains largely unproven in the numbers.

Consumer Care adjusted operating margin was 17.5% in 2025, broadly flat on the prior year's 17.4%. Volume grew 9% but price/mix was negative 1.1%, meaning margin improvement from higher utilisation is being absorbed by selling cheaper product through shared manufacturing sites. The transformation programme delivered £28m of benefits in 2025 with £72m still to come by 2028, making the margin target of 20%+ at group level heavily dependent on future execution rather than anything yet in the numbers. ROIC for the group stands at 8.2%, below any reasonable estimate of cost of capital. Beauty Actives, the sub-segment including new launches such as Zenakine, is disclosed only as a top-line growth figure of 6% at constant currency. No margin, revenue contribution or profitability data is provided for it.

We know it launched. April 2025 to be exact. Was that token of distribution aid for the lads?

You can see the stressed relationship in that mention looool

Can you explain the 'Binary Play' to me. I don't know much about that stuff

Actually the block cycles are only starting. blocks need to complete to be printed. In low liquidity and bad sentiment, it takes a bit of time to complete sell blocks. 'They are coming'

Morning mon ami's

Oh. Never heard of them. Must be a new Inc?

Time for the morning cycle. See if i can find any roadkill for dinner. It's great to get the blood flowing first thing. Highly recommend it. It gives you market superpowers. An oxygen fed brain is far better than a forum fed one you know.

OPTI 6p SBTX 5p

Don't know what to say. Hope payments are not via shares lol

I always believed most of the SBTX supporters online were real investors. Was I being naïve? Maybe the clue was in the 24/7 multi-platform operations

Wow. I mean, are you lot actually investors or full time multi-media promotors?

Doesn't seem as toxic as the RNS's to me. Telegram? How many places do you lot actually operate daily?

Come on lads. If you think the 125K on Friday wasn't a distribution primer then, surely you do now

190,000 was me. A buy

Gotta feeling - a ping is not far away

What a price to be seeing blue strike 7 delta elite appear

Are they going to suspend this a tick above the record low? when all trapped at last price? or let it crash?

Yes just like that.